XOMA Royalty (XOMA) Non-Current Assets (2010 - 2026)

XOMA Royalty (XOMA) reported Non-Current Assets of $153.1 million for Q1 2026, up 53.84% on a YoY basis from $99.5 million in Q1 2025, and down 1.5% sequentially from $155.4 million in Q4 2025.

XOMA Royalty (XOMA) Non-Current Assets (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Non-Current Assets data on file, last reported at $153.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 53.84% year-over-year to $153.1 million; the trailing twelve-month figure through Mar 2026 stood at $526.6 million (up 54.61% YoY), and the FY2025 full-year result was $155.4 million, up 62.47% from the prior year.
  • Non-Current Assets eased to $153.1 million in Q1 2026, from $155.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $155.4 million in Q4 2025 to a low of $64.3 million in Q3 2024.
  • A 5-year average of $90.8 million and a median of $84.2 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets declined 28.21% in 2024 and jumped 62.47% in 2025, its largest moves.
  • Tracing XOMA's Non-Current Assets over 5 years: stood at $79.1 million in 2022, then decreased by 17.87% to $65.0 million in 2023, then jumped by 47.22% to $95.7 million in 2024, then jumped by 62.47% to $155.4 million in 2025, then declined by 1.5% to $153.1 million in 2026.
  • Business Quant data shows XOMA's Non-Current Assets at $153.1 million in Q1 2026, $155.4 million in Q4 2025, and $118.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 153.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 153.11 Mn
Dec 31, 2025 155.44 Mn
Jun 30, 2025 118.53 Mn
Mar 31, 2025 99.53 Mn
Dec 31, 2024 95.67 Mn
Sep 30, 2024 64.32 Mn
Jun 30, 2024 81.08 Mn
Mar 31, 2024 72.53 Mn
Dec 31, 2023 64.99 Mn
Sep 30, 2023 89.59 Mn
Jun 30, 2023 87.24 Mn
Mar 31, 2023 88.59 Mn
Dec 31, 2022 79.13 Mn
Sep 30, 2022 66.39 Mn
Jun 30, 2022 66.96 Mn
Mar 31, 2022 69.55 Mn
Dec 31, 2021 69.59 Mn
Sep 30, 2021 55.63 Mn
Jun 30, 2021 48.50 Mn
Mar 31, 2021 49.65 Mn